SitesBLAST
Comparing WP_011024463.1 NCBI__GCF_000007345.1:WP_011024463.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
7yc6A Crystal structure of d110p mutant of gatase subunit of methanocaldococcus jannaschii gmp synthetase
51% identity, 96% coverage: 6:186/189 of query aligns to 2:178/183 of 7yc6A
1gpmA Escherichia coli gmp synthetase complexed with amp and pyrophosphate (see paper)
33% identity, 94% coverage: 5:182/189 of query aligns to 7:195/501 of 1gpmA
Sites not aligning to the query:
- active site: 237, 357
- binding adenosine monophosphate: 231, 232, 233, 258, 313
- binding pyrophosphate 2-: 233, 235, 236, 237, 238, 357
2ywcA Crystal structure of gmp synthetase from thermus thermophilus in complex with xmp
36% identity, 96% coverage: 6:186/189 of query aligns to 2:184/475 of 2ywcA
Sites not aligning to the query:
5tw7F Crystal structure of a gmp synthase (glutamine-hydrolyzing) from neisseria gonorrhoeae
35% identity, 98% coverage: 1:186/189 of query aligns to 1:192/490 of 5tw7F
Sites not aligning to the query:
3uowA Crystal structure of pf10_0123, a gmp synthetase from plasmodium falciparum
30% identity, 96% coverage: 5:186/189 of query aligns to 3:219/517 of 3uowA
Sites not aligning to the query:
Q8IJR9 GMP synthase [glutamine-hydrolyzing]; PfGMPS; Glutamine amidotransferase; Guanosine monophosphate synthetase; EC 6.3.5.2 from Plasmodium falciparum (isolate 3D7) (see 3 papers)
30% identity, 96% coverage: 5:186/189 of query aligns to 8:229/555 of Q8IJR9
- Y18 (≠ F15) mutation to F: Slight increase in affinity for glutamine. No defect in glutaminase activity.
- H20 (= H17) mutation to A: Slight decrease in affinity for glutamine. 1.8-fold increase in affinity for ATP. Slight increase in affinity for XMP. Moderate reduction in glutaminase activity.
- K24 (≠ R21) mutation to L: 50 percent decrease in glutaminase activity. 5.3-fold decrease in affinity for glutamine. 1.7-fold increase in affinity for ATP. 2.8-fold decrease in affinity for XMP.
- R25 (≠ A22) mutation to L: No effect on glutaminase activity. 1.4-fold decrease in affinity for glutamine.
- C89 (= C79) mutation to A: Loss of glutaminase activity, however, glutamine binding is not affected. In presence of exogenous ammonia, the amination of XMP to produce GMP is normal. 2.3-fold decrease in affinity for ATP and 1.8-fold decrease in affinity for XMP. 2.9-fold decrease in affinity for ATP and 1.9-fold decrease in affinity for XMP; when associated with A-113.
- Q93 (= Q83) binding L-glutamine
- C113 (≠ E103) mutation to A: 2.9-fold decrease in affinity for ATP and 1.9-fold decrease in affinity for XMP; when associated with A-89.
- K160 (vs. gap) mutation to L: No effect on glutaminase activity. 1.2-fold decrease in affinity for ATP. 1.8-fold decrease in affinity for XMP.
- W167 (= W125) mutation to F: Slight decrease in affinity for glutamine. Slight increase in glutaminase activity.
- N169 (≠ S127) binding L-glutamine; mutation to S: Slight increase in affinity for glutamine. No defect in glutaminase activity.
- D172 (= D130) binding L-glutamine; mutation to A: 172-fold decrease in affinity for glutamine. Severe loss of glutaminase activity.
- H208 (= H166) binding L-glutamine
- Y212 (≠ S170) mutation to W: 2.7-fold decrease in affinity for glutamine. No defect in glutaminase activity.
- E213 (≠ H171) mutation to A: 40 percent decrease in glutaminase activity. 1.4-fold decrease in affinity for glutamine. 1.3-fold decrease in affinity for ATP. 1.8-fold decrease in affinity for XMP.
Sites not aligning to the query:
- 336 binding XMP
- 371 Important for ATPPase activity; D→A: Impaired formation of adenyl-XMP intermediate. Slight increase in glutaminase activity.
- 374 E→L: 8.9-fold decrease in affinity for ammonia. Severe loss of glutaminase activity.
- 376 K→L: 20 percent decrease in glutaminase activity. 4.4-fold decrease in affinity for glutamine. 1.8-fold decrease in affinity for XMP.
- 386 K→L: Severe loss of ATP pyrophosphatase (ATPPase) activity. 80 percent decrease in glutaminase activity. Impaired GMP formation.
- 387 T→A: No effect on ATP pyrophosphatase (ATPPase) activity. 20 percent decrease in glutaminase activity. No effect on GMP formation.
- 388 Important for ATPPase activity; H→A: Moderate decrease in ATP pyrophosphatase (ATPPase) activity. Reduces 49 percent decrease in glutaminase activity. Impaired GMP formation.
- 389 Important for ATPPase activity; H→A: Loss of ATP pyrophosphatase (ATPPase) activity. 67 percent decrease in glutaminase activity. Impaired GMP formation.
- 390 N→A: No effect on ATP pyrophosphatase (ATPPase) activity. Increases glutaminase activity. Loss of GMP formation.
- 411 K→L: 70 percent decrease in glutaminase activity. Loss of GMP formation.
- 412 D→A: 30 percent decrease in glutaminase activity. 7.9-fold decrease in affinity for glutamine.
- 413 D→A: 35 percent decrease in glutaminase activity. 3.6-fold decrease in affinity for glutamine.
- 415 K→L: Increases glutaminase activity. 4.2-fold decrease in affinity for ATP.
- 476 binding XMP
- 539 R→L: 85 percent decrease in glutaminase activity.
- 547 binding XMP; K→L: 85 percent decrease in glutaminase activity.
- 552 binding XMP
- 553 binding XMP; E→L: 85 percent decrease in glutaminase activity.
- 555 E→L: 20 percent decrease in glutaminase activity. No effect on GMP formation.
4wioA Crystal structure of the c89a gmp synthetase inactive mutant from plasmodium falciparum in complex with glutamine (see paper)
30% identity, 96% coverage: 5:186/189 of query aligns to 2:218/525 of 4wioA
Sites not aligning to the query:
P00903 Aminodeoxychorismate synthase component 2; ADC synthase; ADCS; 4-amino-4-deoxychorismate synthase component 2; Aminodeoxychorismate synthase, glutamine amidotransferase component; EC 2.6.1.85 from Escherichia coli (strain K12) (see paper)
34% identity, 94% coverage: 6:183/189 of query aligns to 2:185/187 of P00903
- C79 (= C79) mutation to S: 10000-fold decrease in catalytic efficiency.
- H168 (= H166) mutation to Q: Loss of activity.
- E170 (= E168) mutation to A: 150-fold decrease in catalytic efficiency.; mutation to D: 4-fold decrease in catalytic efficiency.; mutation E->K,Q: Loss of activity.
3uowB Crystal structure of pf10_0123, a gmp synthetase from plasmodium falciparum
33% identity, 96% coverage: 5:186/189 of query aligns to 1:183/477 of 3uowB
Sites not aligning to the query:
8hx8A Crystal structure of 4-amino-4-deoxychorismate synthase from streptomyces venezuelae co-crystallized with chorismate (see paper)
30% identity, 96% coverage: 2:182/189 of query aligns to 2:187/673 of 8hx8A
Sites not aligning to the query:
- binding magnesium ion: 521, 655, 658
- binding tryptophan: 231, 232, 233, 241, 243, 458, 459, 460, 614
2vxoB Human gmp synthetase in complex with xmp (see paper)
33% identity, 94% coverage: 6:183/189 of query aligns to 6:182/658 of 2vxoB
Sites not aligning to the query:
- active site: 223, 381
- binding xanthosine-5'-monophosphate: 302, 348, 349, 404, 405, 406, 489, 575, 610, 650, 654, 655, 656
P49915 GMP synthase [glutamine-hydrolyzing]; GMP synthetase; Glutamine amidotransferase; EC 6.3.5.2 from Homo sapiens (Human) (see paper)
32% identity, 94% coverage: 6:183/189 of query aligns to 28:207/693 of P49915
- C104 (= C79) active site, For GATase activity
- H190 (= H166) active site, For GATase activity
- E192 (= E168) active site, For GATase activity
Sites not aligning to the query:
- 337 binding XMP
- 522 binding XMP
- 610 binding XMP
- 685 binding XMP
- 691 binding XMP
1ce8B Carbamoyl phosphate synthetase from escherichis coli with complexed with the allosteric ligand imp (see paper)
30% identity, 90% coverage: 19:189/189 of query aligns to 204:376/379 of 1ce8B
Sites not aligning to the query:
P0A6F1 Carbamoyl phosphate synthase small chain; Carbamoyl phosphate synthetase glutamine chain; EC 6.3.5.5 from Escherichia coli (strain K12) (see paper)
30% identity, 90% coverage: 19:189/189 of query aligns to 205:377/382 of P0A6F1
- G241 (= G55) binding L-glutamine
- G243 (vs. gap) binding L-glutamine
- L270 (= L80) binding L-glutamine
- Q273 (= Q83) binding L-glutamine
- N311 (≠ A126) binding L-glutamine
- G313 (≠ S127) binding L-glutamine
- F314 (≠ H128) binding L-glutamine
Sites not aligning to the query:
Q42565 Anthranilate synthase beta subunit 1, chloroplastic; Anthranilate synthase component 2-1; Anthranilate synthase, glutamine amidotransferase component 2-1; Protein TRYPTOPHAN BIOSYNTHESIS 4; Protein WEAK ETHYLENE INSENSITIVE 7; EC 4.1.3.27 from Arabidopsis thaliana (Mouse-ear cress) (see 2 papers)
25% identity, 97% coverage: 6:188/189 of query aligns to 75:269/276 of Q42565
- G150 (= G77) mutation to D: In trp4-1; no visible phenotype under normal growth conditions.
- G176 (= G99) mutation to E: In wei7-2; insensitive to inhibition of root elongation by ethylene.
P07258 Carbamoyl phosphate synthase arginine-specific small chain; CPS; CPSase; CPSase-arg; Arginine-specific carbamoyl phosphate synthetase, glutamine chain; Carbamoyl phosphate synthase A; CPS-A; Glutamine-dependent carbamoyl phosphate synthetase; EC 6.3.5.5 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see paper)
32% identity, 90% coverage: 19:189/189 of query aligns to 197:373/411 of P07258
- C264 (= C79) mutation to D: Abolishes glutamine-dependent CPSase activity.
- H307 (≠ A126) mutation to D: Abolishes glutamine-dependent CPSase activity.
- H349 (= H166) mutation to D: Abolishes glutamine-dependent CPSase activity.
1c3oB Crystal structure of the carbamoyl phosphate synthetase: small subunit mutant c269s with bound glutamine (see paper)
29% identity, 90% coverage: 19:189/189 of query aligns to 204:376/379 of 1c3oB
- active site: S268 (≠ C79), H352 (= H166), E354 (= E168)
- binding glutamine: N239 (≠ G54), G240 (= G55), G242 (vs. gap), S268 (≠ C79), L269 (= L80), N310 (≠ A126), H311 (vs. gap), G312 (≠ S127), F313 (≠ H128)
Sites not aligning to the query:
8hx9A Crystal structure of 4-amino-4-deoxychorismate synthase from streptomyces venezuelae with chorismate (see paper)
26% identity, 96% coverage: 2:182/189 of query aligns to 1:144/632 of 8hx9A
Sites not aligning to the query:
- binding (3R,4R)-3-[(1-carboxyethenyl)oxy]-4-hydroxycyclohexa-1,5-diene-1-carboxylic acid: 453, 454, 455, 456, 547, 570, 590, 603, 604, 605, 606, 619, 623
- binding tryptophan: 189, 190, 191, 199, 201, 419, 420, 421, 574, 575
P00900 Anthranilate synthase component 2; AS; ASII; Anthranilate synthase, GATase component; Anthranilate synthase, glutamine amidotransferase component; EC 4.1.3.27 from Serratia marcescens (see 3 papers)
30% identity, 92% coverage: 6:179/189 of query aligns to 4:183/193 of P00900
- C84 (= C79) active site, Nucleophile; for GATase activity
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
P08955 Multifunctional protein CAD; Carbamoyl phosphate synthetase 2-aspartate transcarbamylase-dihydroorotase; EC 6.3.5.5; EC 3.5.1.2; EC 6.3.4.16; EC 2.1.3.2; EC 3.5.2.3 from Mesocricetus auratus (Golden hamster) (see paper)
30% identity, 74% coverage: 44:183/189 of query aligns to 211:353/2225 of P08955
Sites not aligning to the query:
- 1406 modified: Phosphoserine; by PKA; S→A: No effect on enzyme kinetics.; S→D: Increases CPSase activity and reduces sensitivity to feedback inhibition by UTP.
Query Sequence
>WP_011024463.1 NCBI__GCF_000007345.1:WP_011024463.1
MRELKILVVNNYGQFCHLIHRAVRDLDMDTKIIPNVTPIEDILAEEPDGLILSGGPEMER
AGLCFDYVREIDIPILGICLGHQAIALAYGGHVHSGKKGGYAEIEIEVIEEDDILRGLGP
KITVWASHADEVAILPEGFIHLARSDICEIEAMRHPTKPIYGVQWHPEVSHTKKGDELLT
NFFEVCDRY
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory